WNT3A and malignant colon neoplasm: Indeed, recently it has been reported that using Wnt3a and Wnt5a as prototype ligands to activate the canonical or the non-canonical pathways, respectively, promotes sphere-formation capacity and proliferation through the β-catenin-independent manner in colon cancer cells [24].